Fundraising Fox
/Companies
Sign in

Ronatherapeutics

Shanghai, CN · 3 known investors

Find your way into Ronatherapeutics

Sign up to find every way you can get introduced to Ronatherapeutics

  • Your email: who you already know at Ronatherapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ronatherapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Rona Therapeutics develops siRNA-based therapeutics using its GAIA platform to target metabolic and cardiovascular conditions including hypertriglyceridemia, obesity, ASCVD, and MASH. Its pipeline includes APOC3, INHBE, PCSK9-Lp(a), and angiotensinogen-targeting candidates for patients with cardiovascular and metabolic diseases.

BiotechLongevity

Founders & leadership

JHJinyu Huang
Jinyu HuangChief Executive Officer, Founder
SSStella Shi
Stella ShiFounder & Chief Executive Officer, Chair of the Board

Investors · 3

LAVlisted by LAVHong Kong · $5M – $15M
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred

How we know: the VCSheet dataset · Not right? Tell us

Frequently asked questions

What does Ronatherapeutics do?
Rona Therapeutics develops siRNA-based therapeutics using its GAIA platform to target metabolic and cardiovascular conditions including hypertriglyceridemia, obesity, ASCVD, and MASH. Its pipeline includes APOC3, INHBE, PCSK9-Lp(a), and angiotensinogen-targeting candidates for patients with cardiovascular and metabolic diseases.
Who founded Ronatherapeutics?
Ronatherapeutics was founded by Jinyu Huang, Stella Shi.
Who are Ronatherapeutics's investors?
Ronatherapeutics's investors include B Capital Group, LAV, Lilly Asia Ventures.
Where is Ronatherapeutics headquartered?
Ronatherapeutics is headquartered in Shanghai, CN.